ISSN: 1308-5727 | E-ISSN: 1308-5735
Volume : Issue : Year : 2024
Forms

Abstracting & Indexing
Turkish Society for Pediatric Endocrinology and Diabetes
A Boy with 46,XX Karyotype (SRY double-positive) having a Leydig Cell Tumor [J Clin Res Pediatr Endocrinol]
J Clin Res Pediatr Endocrinol. Ahead of Print: JCRPE-07769 | DOI: 10.4274/jcrpe.galenos.2023.2022-9-14

A Boy with 46,XX Karyotype (SRY double-positive) having a Leydig Cell Tumor

Merve Gullu1, Sultan AYDIN2, Tarkan KALKAN3, Tangül PINARCI4, Doğa TURKKAHRAMAN1
1Department of Pediatric Endocrinology, University of Health Science, Antalya Training and Research Hospital, Antalya, Turkey
2Department of Pediatric Hematology and Oncology, Antalya Training and Research Hospital, Antalya, Turkey
3Bio-Gen Genetic Diseases Evaluation Center, Antalya, Turkey
4Department of Pathology, Antalya Training and Research Hospital, Antalya, Turkey

Leydig cell tumors are the most common type of testicular sex cord stromal tumors. Presence of Y chromosome is associated with tumor risk in sex development disorder (DSD), however tumor development without Y chromosome are extremely rare. A 16-year-old boy diagnosed with Leydig cell tumor due to a mass in the right testis was referred after the right orchiectomy. In physical examination, left testis was 10 ml, and a labium residue in penoscrotal region with bilateral gynecomastia was present. Karyotype was 46,XX, and SRY was double-positive in FISH analysis. Ifosfamide, carboplatin and etoposide chemotherapy was initiated due to Leydig cell tumor. Here, we report the first pediatric case having 46,XX, SRY double-positive testicular DSD with Leydig cell tumor.

Keywords: Testicular DSD, SRY, Leydig cell tumor



Corresponding Author: Doğa TURKKAHRAMAN, Türkiye
Manuscript Language: English
LookUs & Online Makale